BU researchers receive NIH grant to identify genetic factors for Alzheimer’s disease

The National Institutes of Health/National Institute on Aging recently awarded a $13.7 million grant to a project led by Boston University Chobanian & Avedisian School of Medicine principal investigators Lindsay Farrer, PhD, chief of biomedical genetics and distinguished professor of genetics, and Richard Sherva, PhD, assistant professor of medicine in biomedical genetics, for research using whole genome sequencing and other approaches to identify genetic factors for Alzheimer disease (AD) in Jews currently living in Israel who trace their ancestors to southern Spain and locations in the Middle East and North Africa (MENA) and Arab citizens of Israel.

Investigational Agent Shows Benefit in Myasthenia Gravis

The investigational monoclonal antibody batoclimab led to significant improvement in activities of daily living in people with generalized myasthenia gravis (gMG), a multicenter phase III

March 6, 2024

Updated: FDA approves Sarepta’s Duchenne muscular dystrophy gene therapy via accelerated pathway

The FDA granted accelerated approval to Sarepta Therapeutics’ Duchenne muscular dystrophy gene therapy for boys aged 4 and 5 in a decision that allows access

June 23, 2023

‘Missed opportunities’: Why a U.K. government plan to disclose financial ties between pharma and docs may fall short

Earlier this month, the U.K. government issued a proposal to gather information and opinions about payments that drug and device makers give to the medical

October 24, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.